HIGH logo

Cantourage Group SE Stock Price

XTRA:HIGH Community·€37.4m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 5 Fair Values set on narratives written by author

HIGH Share Price Performance

€3.00
-1.72 (-36.44%)
€3.00
-1.72 (-36.44%)
Price €3.00

HIGH Community Narratives

There are no narratives available yet.

Snowflake Analysis

High growth potential with adequate balance sheet.

3 Risks
2 Rewards

Cantourage Group SE Key Details

€2.0m

Revenue

€0

Cost of Revenue

€2.0m

Gross Profit

€2.1m

Other Expenses

-€95.5k

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.0077
100.00%
-4.74%
0%
View Full Analysis

About HIGH

Founded
2019
Employees
7
CEO
Philip Schetter
WebsiteView website
www.cantourage.com

Cantourage Group SE operates as a medical cannabis company in Europe. It offers dried flowers, extracts, dronabinol products, and pharma-grade cannabidiol products. The company was founded in 2019 and is based in Kleinmachnow, Germany.

Recent HIGH News & Updates

Cantourage Group SE's (ETR:HIGH) Intrinsic Value Is Potentially 56% Above Its Share Price

Sep 09
Cantourage Group SE's (ETR:HIGH) Intrinsic Value Is Potentially 56% Above Its Share Price

Recent updates

No updates